The ESMO-affiliated Association of Medical Oncologists of Serbia (UMOS) and the EACR-associated Serbian Association for Cancer Research (SDIR) organized the first UMOS-SDIR Colloquium on Liquid Biopsy in Oncology, on February 26, 2025. The colloquium was a conversation between experts about liquid biopsy issues that are imposed by the constant advancement of cancer research and clinical oncology, and about solutions that are not yet in the corpus of recommendations nor a part of international and national clinical practice.
Dr Remond Fijneman, from the Netherlands Cancer Institute delivered an ELBS-endorsed Plenary Lecture: “Circulating tumor DNA: innovative diagnostics to better determine who, how, and when to treat” supporting the meeting with a perspective from the Dutch national experience.
Meeting participants highlighted technological progress and outlined future steps in the more precise monitoring of the biology of malignant tumors and the response to treatment, using lung and colorectal cancer as models. As an outcome of the meeting, the directions of future joint activities were determined, in order to formulate a clear national strategy for the clinical application of liquid biopsy in oncology in Serbia.
